348 Participants Needed

Clinician Training Program for Long COVID

LM
SN
Overseen ByShannon Nugent, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a special training program for doctors can improve care for Veterans dealing with Long-COVID. The program focuses on teaching doctors to engage in meaningful conversations with patients, validate their experiences, and collaborate on a care plan. Veterans experiencing persistent COVID-19 symptoms and who have appointments with participating doctors might be suitable candidates. The trial consists of two parts, testing two different training methods: Concordant Care Training and Education Packet Training, to identify which method enhances doctors' ability to provide better care. As an unphased trial, this study offers Veterans an opportunity to contribute to improving healthcare practices for Long-COVID.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on training clinicians rather than changing participants' medication routines.

What prior data suggests that this training program is safe for clinicians and patients?

A previous study showed that Concordant Care creates positive experiences for patients with complex conditions. This approach emphasizes recognizing and understanding patients' experiences and collaborating to develop personalized care plans. These elements make it well-received because the care centers on patients' needs.

No known negative effects are directly linked to Concordant Care Training. It is important to note that this is not a drug or medical procedure. Instead, it is a training program for healthcare providers to enhance their interactions with patients. Therefore, there are no physical side effects like those associated with medications. Since it is not a traditional clinical trial, there is no specific phase for safety evidence. However, the program's design suggests it is a safe way to improve patient-provider relationships.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to improve how healthcare providers manage Long COVID through specialized training. Unlike traditional approaches that focus solely on patient treatment, this trial emphasizes equipping clinicians with enhanced skills and knowledge. The Concordant Care Training offers a hands-on approach to align care with patient needs, while the Education Packet Training provides structured learning materials. By focusing on clinician training, the trial hopes to improve patient outcomes through more personalized and informed care.

What evidence suggests that this trial's treatments could be effective for Long-COVID?

Research shows that the Concordant Care approach improves patient experiences by acknowledging their feelings, creating mutual understanding, and developing personalized care plans. Strong evidence indicates that both patients and doctors report positive experiences, especially for conditions not well understood, like Long COVID. Studies have found that when doctors use this approach, patients feel more understood and supported, leading to greater satisfaction and better adherence to care plans. In this trial, providers will be randomized to receive either Concordant Care Training or Education Packet Training. Although promising, no specialized training programs currently exist for doctors to use Concordant Care specifically for Long COVID. The goal is to adapt this approach to improve care and outcomes for Veterans dealing with this challenging condition.24678

Who Is on the Research Team?

LM

Lisa Marie McAndrew, PhD

Principal Investigator

East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ

Are You a Good Fit for This Trial?

This trial is for English-speaking VA primary care providers and Veterans with Long-COVID who are receiving care in the VA. Providers must not have prior Concordant Care training, and Veterans need to have an upcoming appointment within 1-6 months after clinician consent.

Inclusion Criteria

Part 2, Veterans must also have a scheduled appointment with one of the participating clinicians within one to six months of the clinician being consented.
Veterans who have Long-COVID symptoms as determined by a specific questionnaire will be included.
I am an English-speaking VA primary care provider.
See 1 more

Exclusion Criteria

Part 1 and Part 2, clinicians who have already taken Concordant Care training will be excluded.
Part 1, Veterans will be excluded if they are not receiving care in the VA.
Part 2, Veterans will be excluded if they were in the Intensive Care Unit (ICU) for COVID-19.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training and Optimization

Part 1 of the study will optimize and test if a Concordant Care training improves VA clinicians' engagement in recommended practices to provide Concordant Care for Veterans with Long-COVID.

Varies
Interviews and focus groups

Randomized Parallel Cluster Trial

Part 2 of the study will determine if Concordant Care training increases clinicians' engagement in recommended practices and explore the effectiveness of Concordant Care on care outcomes.

3 months
Baseline and follow-up assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Concordant Care Training
  • Education Packet Training
Trial Overview The study tests a Concordant Care training program for clinicians treating Long-COVID. It aims to see if this training helps them engage better with patients by validating experiences, understanding conditions together, and planning patient-centered actions.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Providers receiving Long-COVID Concordant Care TrainingExperimental Treatment1 Intervention
Group II: Providers receiving Education Packet TrainingActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

The Duke-Watts Family Medicine Program successfully integrated geriatric medicine training into its residency program by involving residents in the planning process and focusing on practical, relevant goals.
Key strategies included developing a conference series, identifying training sites, and incorporating various healthcare professionals, which enhanced the training experience across different care settings.
Geriatric training in family medicine: the natural history of a developing program.Moore, JT., Kane, WJ.[2004]
The COVID-19 Clinical Rounds Initiative, developed by the US Department of Health and Human Services and the University of New Mexico, created a large-scale peer-to-peer learning network to enhance clinical education during the pandemic, engaging participants from all 50 states and over 100 countries.
Between March 2020 and February 2021, the initiative conducted 125 learning sessions, providing more than 58,000 hours of educational contact, focusing on critical areas of COVID-19 care such as emergency medical services, emergency departments, and inpatient critical care.
Virtual Peer-to-Peer Learning to Enhance and Accelerate the Health System Response to COVID-19: The HHS ASPR Project ECHO COVID-19 Clinical Rounds Initiative.Hunt, RC., Struminger, BB., Redd, JT., et al.[2022]
A rapid training program for contact tracing and case investigation was developed and successfully scaled, training 7,499 individuals in California from April to August 2020, demonstrating the feasibility of quickly mobilizing a workforce to combat COVID-19.
The training emphasized interactive, skills-based learning, particularly in rapport building and health coaching, which are crucial for effective case investigation and contact tracing, highlighting the importance of practical training and feedback in public health education.
California's COVID-19 Virtual Training Academy: Rapid Scale-Up of a Statewide Contact Tracing and Case Investigation Workforce Training Program.Brickley, DB., Forster, M., Alonis, A., et al.[2021]

Citations

NCT05787379 | Care for Veterans Post-COVID-19Part 1 of the study will optimize and test if a Concordant Care training improves VA clinicians' engagement in recommended practices to provide Concordant Care ...
Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection ...Long COVID/PASC is the continuation or development of new symptoms after three months from the initial SARS-CoV-2 infection, which lasts for at least two ...
VA Funded Studies on Long COVIDThe CORC conducts and supports rigorous research to understand the long-term effects of SARS-CoV-2 infection. To achieve this goal,. CORC will ...
Post-acute sequelae of SARS-CoV-2 infection (Long COVID ...Determinants of post-COVID-19 symptoms among adults aged 55 or above with chronic conditions in primary care: data from a prospective cohort in Hong Kong.
Patient-reported treatment outcomes in ME/CFS and long ...With no known effective FDA-approved treatments for either condition, patient-reported outcomes of treatments may prove helpful in identifying management ...
Save SelectedThe evidence-based Concordant Care approach involves engaging in processes that: 1) validate the patient's experience, 2) develop a shared understanding of ...
Acute Sequelae of SARS-CoV-2 (PASC)/Long COVID ...Persistent inflammation could help explain the variability of PASC/long COVID manifestations - through different types of inflammatory activation, responses to ...
Post-acute sequelae of severe acute respiratory syndrome ...Objective: To estimate the prevalence of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) after infection ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security